Yanai H, Adachi H, Hakoshima M, Iida S, Katsuyama H. Metabolic-Dysfunction-Associated steatotic liver Disease-Its pathophysiology, association with atherosclerosis and cardiovascular disease, and treatments. Int J Mol Sci. 2023;24(20):15473.

PubMed  PubMed Central  Google Scholar 

Duseja A, Najmy S, Sachdev S, Pal A, Sharma RR, Marwah N, et al. High prevalence of non-alcoholic fatty liver disease among healthy male blood donors of urban India. JGH Open. 2019;3(2):133–9.

PubMed  PubMed Central  Google Scholar 

Kumar A, Sharma A, Duseja A, Das A, Dhiman RK, Chawla YK, et al. Patients with nonalcoholic fatty liver disease (NAFLD) have higher oxidative stress in comparison to chronic viral hepatitis. J Clin Exp Hepatol. 2013;3(1):12–8.

PubMed  Google Scholar 

Hjelkrem M, Morales A, Williams CD, Harrison SA. Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH). Aliment Pharmacol Ther. 2012;35(12):1416–23.

PubMed  Google Scholar 

King D, Armstrong MJ. Overview of Gilbert’s syndrome. Drug Ther Bull. 2019;57(2):27–31.

PubMed  Google Scholar 

Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A. Unconjugated hyperbilirubinemia in nonalcoholic steatohepatitis–is it Gilbert’s syndrome? Trop Gastroenterol. 2005;26(3):123–5.

PubMed  Google Scholar 

Luo L, An P, Jia X, Yue X, Zheng S, Liu S, et al. Genetically regulated bilirubin and risk of non-alcoholic fatty liver disease: A Mendelian randomization study. Front Genet. 2018;9:662.

PubMed  PubMed Central  Google Scholar 

Xie Y, Miranda SR, Hoskins JM, Hawke RL. Role of UDP-Glucuronosyltransferase 1A1 in the metabolism and pharmacokinetics of Silymarin flavonolignans in patients with HCV and NAFLD. Molecules. 2017;22(1):142.

PubMed  PubMed Central  Google Scholar 

Lin YC, Chang PF, Hu FC, Chang MH, Ni YH. Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease. Pediatrics. 2009;124(6):e1221–7.

PubMed  Google Scholar 

Landerer S, Kalthoff S, Paulusch S, Strassburg CP. A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized Transgenic mice. Sci Rep. 2020;10(1):8689.

PubMed  PubMed Central  Google Scholar 

De Silva AP, Prabagar K, Wickramasinghage AS, Wanniarachchi AA, Ediriweera DS, Niriella MA, De Silva HJ. The significance of the presence of Gilbert’s syndrome in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A retrospective cohort study. Cureus. 2025;17(5):e85074. PMID: 40585738; PMCID: PMC12206347. https://doi.org/10.7759/cureus.85074.

Article  PubMed  PubMed Central  Google Scholar 

Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009 May-Jun;2(5–6):231-7. https://doi.org/10.1242/dmm.001180. PMID: 19407331; PMCID: PMC2675814.

Pan W-H, Yeh W-T. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac J Clin Nutr. 2008;17:370–4.

PubMed  Google Scholar 

Duseja A, Singh SP, Saraswat VA, Acharya SK, Chawla YK, Chowdhury S, et al. Non-alcoholic fatty liver disease and metabolic Syndrome-Position paper of the Indian National Association for the Study of the Liver, Endocrine Society of india, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol. 2015;5(1):51–68.

PubMed  PubMed Central  Google Scholar 

Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol. 2014;5(3):211–8.

PubMed  Google Scholar 

Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA, NASH Clinical Research Network (CRN). Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011;53(3):810–20.

PubMed  Google Scholar 

Stillman AE. Jaundice. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 87. Available from: https://www.ncbi.nlm.nih.gov/books/NBK413/

Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician. 2004;69(2):299–304.

PubMed  Google Scholar 

Shrestha O, Khadwal AR, Singhal M, Trehan A, Bansal D, Jain R, et al. A high frequency of Gilbert syndrome (UGT1A1*28/*28) and associated hyperbilirubinemia but not cholelithiasis in adolescent and adult North Indian patients with transfusion-dependent β-thalassemia. Ann Hematol. 2020;99(9):2019–26.

PubMed  Google Scholar 

Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci U S A. 1998;95(14):8170–4.

PubMed  PubMed Central  Google Scholar 

Kumar R, Rastogi A, Maras JS, Sarin SK. Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: a favorable endogenous response. Clin Biochem. 2012;45(3):272–4.

PubMed  Google Scholar 

Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol. 2006;40(10):930–5.

PubMed  Google Scholar 

Chiddarwar AS, D’Silva SZ, Colah RB, Ghosh K, Mukherjee MB. Genetic variations in bilirubin metabolism genes and their association with unconjugated hyperbilirubinemia in adults. Ann Hum Genet. 2017;81(1):11–9.

PubMed  Google Scholar 

Premawardhena A, Fisher CA, Liu YT, Verma IC, de Silva S, Arambepola M, et al. The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications. Blood Cells Mol Dis. 2003;31(1):98–101.

PubMed  Google Scholar 

Agrawal SK, Kumar P, Rathi R, Sharma N, DAS R, Prasad R, et al. UGT1A1 gene polymorphisms in North Indian neonates presenting with unconjugated hyperbilirubinemia. Pediatr Res. 2009;65(6):675–80.

PubMed  Google Scholar 

Hemmati F, Saki F, Saki N, Haghighat M. Gilbert syndrome in Iran, Fars Province. Ann Saudi Med. 2010;30(1):84.

PubMed  PubMed Central  Google Scholar 

Lin JP, Vitek L, Schwertner HA. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem. 2010;56(10):1535–43.

PubMed  Google Scholar 

Ong KL, Allison MA, Cheung BM, Wu BJ, Barter PJ, Rye KA. The relationship between total bilirubin levels and total mortality in older adults: the United States National Health and Nutrition Examination Survey (NHANES) 1999–2004. PLoS ONE. 2014;9(4):e94479.

PubMed  PubMed Central  Google Scholar 

Horsfall LJ, Nazareth I, Pereira SP, Petersen I. Gilbert’s syndrome and the risk of death: a population-based cohort study. J Gastroenterol Hepatol. 2013;28(10):1643–7.

PubMed  Google Scholar 

Mazza U, Saglio G, Cappio FC, Camaschella C, Neretto G, Gallo E. Clinical and haematological data in 254 cases of beta-thalassaemia trait in Italy. Br J Haematol. 1976;33(1):91–9.

PubMed  Google Scholar 

Valenti L, Canavesi E, Galmozzi E, Dongiovanni P, Rametta R, Maggioni P, et al. Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease. J Hepatol. 2010;53(5):927–33.

PubMed  Google Scholar